Table 2 Cbx4 expression is positively correlated with histological grading and metastasis of HCC

From: Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma

Variables

Cases

Cbx4 expression, cases (%)

χ 2

P -value

  

Low

High

  

Total

727

263 (100)

464 (100)

  

Gender

   

0.450

0.502

 Female

88 (12.1)

29 (11.0)

59 (12.7)

  

 Male

639 (87.9)

234 (89.0)

405 (87.3)

  

Race

   

0.407

0.524

 Han

478 (65.7)

169 (64.3)

309 (66.6)

  

 Minority

249 (34.3)

94 (35.7)

155 (33.4)

  

HBsAg

   

0.516

0.473

 Negative

91 (12.5)

36 (13.7)

55 (11.9)

  

 Positive

636 (87.5)

227 (86.3)

409 (88.1)

  

Anti-HCV

   

3.538

0.060

 Negative

725 (99.7)

261 (99.2)

464 (100)

  

 Positive

2 (0.3)

2 (0.8)

0 (0)

  

Hepatocirrhosis

   

0.007

0. 932

 No

181 (24.9)

65 (24.7)

116 (25.0)

  

 Yes

546 (75.1)

198 (75.3)

348 (75.0)

  

Smoke

   

0.108

0.743

 No

545 (75.0)

199 (75.7)

346 (74.6)

  

 Yes

182 (25.0)

64 (24.3)

118 (25.4)

  

Drink

   

0.058

0.809

 No

577 (79.4)

210 (79.8)

367 (79.1)

  

 Yes

150 (20.6)

53 (20.2)

97 (20.9)

  

Tumor size (cm)

   

1.688

0.194

 ≤5

171 (23.5)

69 (26.2)

102 (22.0)

  

 >5

556 (76.5)

194 (73.8)

362 (78.0)

  

Tumor number

   

1.083

0.298

 Single

545 (75.0)

203 (77.2)

342 (73.7)

  

 Multiple

182 (25.0)

60 (22.8)

122 (26.3)

  

AFP (ng/ml)

   

0.297

0.586

 <25

311 (42.8)

116 (44.1)

195 (42.0)

  

 ≥25

416 (57.2)

147 (55.9)

269 (58.0)

  

Histological grading

   

4.045

0.044

 Low

340 (46.8)

136 (51.7)

204 (44.0)

  

 High

387 (53.2)

127 (48.3)

260 (56.0)

  

Hematogenous metastasis

   

10.413

0.001

 Absent

157 (21.6)

74 (28.1)

83 (17.9)

  

 Present

570 (78.4)

189 (71.9)

381 (82.1)

  

Distant metastasis

   

4.167

0.041

 No

692 (95.2)

256 (97.3)

436 (94.0)

  

 Yes

35 (4.8)

7 (2.7)

28 (6.0)

  

MVD

   

207.745

4.3 × 10−47

 ≤50

261 (36.0)

184 (70.0)

77 (16.6)

  

 >50

465 (64.0)

79 (30.0)

387 (83.4)

  

TNM stage

   

17.895

1.3 × 10−4

 I–II

138 (19.0)

71 (27.0)

67 (14.4)

  

 III

518 (71.3)

172 (65.4)

346 (74.6)

  

 IV

71 (9.8)

20 (7.6)

51 (11.0)